Establishment Labs Holdings (ESTA) Liabilities and Shareholders Equity (2017 - 2026)

Establishment Labs Holdings (ESTA) recorded quarterly Liabilities and Shareholders Equity of $351.0 million in Q1 2026, down 1.72% quarter-over-quarter from $357.2 million in Q4 2025, and up 5.3% on a YoY basis from $333.4 million in Q1 2025.

Establishment Labs Holdings (ESTA) Liabilities and Shareholders Equity (2017 - 2026) Analysis & Trends

Establishment Labs Holdings' Liabilities and Shareholders Equity history runs 10 years deep, the most recent figure standing at $351.0 million for Q1 2026.

  • In Q1 2026, Liabilities and Shareholders Equity rose 5.3% year-over-year to $351.0 million; the TTM figure through Mar 2026 stood at $1.4 billion (up 10.32% YoY), while the FY2025 annual figure was $357.2 million, up 2.98% from the prior year.
  • Liabilities and Shareholders Equity was $351.0 million for Q1 2026 at Establishment Labs Holdings, down from $357.2 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $357.2 million in Q4 2025 to a low of $141.6 million in Q1 2022.
  • Historically, Liabilities and Shareholders Equity has averaged $276.5 million across 5 years, with a median of $285.1 million in 2024.
  • Biggest YoY gain for Liabilities and Shareholders Equity was 51.27% in 2022; the steepest drop was 7.08% in 2022.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $211.1 million in 2022, then rose by 27.28% to $268.6 million in 2023, then increased by 29.11% to $346.8 million in 2024, then gained by 2.98% to $357.2 million in 2025, then retreated by 1.72% to $351.0 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $351.0 million (Q1 2026), $357.2 million (Q4 2025), and $338.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 110.43 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 46.29 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 91.49 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 13.32 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 31.92 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 6.63 Bn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 37.13 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 10.74 Bn
10 Establishment Labs Holdings 2.54 Bn 2.47 Bn 42.34 Mn 351.04 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 351.04 Mn
Dec 31, 2025 357.17 Mn
Sep 30, 2025 338.90 Mn
Jun 30, 2025 329.67 Mn
Mar 31, 2025 333.36 Mn
Dec 31, 2024 346.83 Mn
Sep 30, 2024 282.69 Mn
Jun 30, 2024 285.09 Mn
Mar 31, 2024 301.84 Mn
Dec 31, 2023 268.64 Mn
Sep 30, 2023 270.53 Mn
Jun 30, 2023 285.30 Mn
Mar 31, 2023 209.36 Mn
Dec 31, 2022 211.06 Mn
Sep 30, 2022 187.65 Mn
Jun 30, 2022 199.88 Mn
Mar 31, 2022 141.56 Mn
Dec 31, 2021 139.53 Mn
Sep 30, 2021 148.36 Mn
Jun 30, 2021 152.12 Mn